copyright and Rybelsus are each produced by Novo Nordisk and comprise a similar active component, semaglutide. They're primarily designed to treat kind 2 diabetic issues. copyright is available as a self-injection pen, though Rybelsus is available in tablet variety.The copyright pen is suitable for ease of use, nonetheless it's necessary to Adhere